HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue.

AbstractBACKGROUND:
Inadequate angiogenic response to ischemia in the myocardium of diabetic patients could result in poor collateral formation. Yet, excessive neovascularization in the retina causes proliferative diabetic retinopathy. Since vascular endothelial growth factor (VEGF) is the major angiogenic factor expressed in response to hypoxia, we have characterized expression of VEGF and its receptors in retina, renal glomeruli, aorta, and myocardium in insulin-resistant and diabetic states. Methods and Results- The expression of mRNA and protein for VEGF and its receptors, VEGF-R1 and VEGF-R2, in the myocardium was decreased significantly by 40% to 70% in both diabetic and insulin-resistant nondiabetic rats. Twofold reductions in VEGF and VEGF-R2 were observed in ventricles from diabetic patients compared with nondiabetic donors. In contrast, expression of VEGF and its receptors were increased 2-fold in retina and glomeruli from diabetic or insulin-resistant rats. Insulin treatment of diabetic rats normalized changes in both cardiac and microvascular tissues. Insulin increased VEGF mRNA expression in cultured rat neonatal cardiac myocytes.
CONCLUSIONS:
The results documented for the first time that differential regulation of VEGF and its receptors exist between microvascular and cardiac tissues, which can be regulated by insulin. These results provide a potential explanation for concomitant capillary leakage and neovascularization in the retina and inadequate collateral formation in the myocardium of insulin-resistant and diabetic patients.
AuthorsEva Chou, Izumi Suzuma, Kerrie J Way, Darren Opland, Allen C Clermont, Keiko Naruse, Kiyoshi Suzuma, Nancy L Bowling, Chris J Vlahos, Lloyd Paul Aiello, George L King
JournalCirculation (Circulation) Vol. 105 Issue 3 Pg. 373-9 (Jan 22 2002) ISSN: 1524-4539 [Electronic] United States
PMID11804995 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endothelial Growth Factors
  • Insulin
  • Lymphokines
  • RNA, Messenger
  • Receptors, Growth Factor
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Receptor Protein-Tyrosine Kinases
  • Receptors, Vascular Endothelial Growth Factor
Topics
  • Animals
  • Cells, Cultured
  • Collateral Circulation
  • Coronary Circulation
  • Diabetes Mellitus (blood, metabolism)
  • Endothelial Growth Factors (genetics, metabolism)
  • Female
  • Gene Expression Regulation (drug effects)
  • Humans
  • Insulin (pharmacology)
  • Insulin Resistance
  • Kidney Glomerulus (metabolism)
  • Lymphokines (genetics, metabolism)
  • Male
  • Middle Aged
  • Myocardium (metabolism)
  • Neovascularization, Pathologic
  • Obesity
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Zucker
  • Receptor Protein-Tyrosine Kinases (genetics, metabolism)
  • Receptors, Growth Factor (genetics, metabolism)
  • Receptors, Vascular Endothelial Growth Factor
  • Retina (metabolism)
  • Transcription, Genetic (drug effects)
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: